228 related articles for article (PubMed ID: 29445424)
1. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
2. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
[TBL] [Abstract][Full Text] [Related]
3. Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
Zhang C; Xu X; Wang T; Lu Y; Lu Z; Wang T; Pan Z
Sci Rep; 2024 Apr; 14(1):7941. PubMed ID: 38575639
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of PRPF19 immune infiltrates, DNA methylation, senescence-associated secretory phenotype and ceRNA network in bladder cancer.
Wang Y; Wang J; He J; Ji B; Pang Z; Wang J; Liu Y; Ren M
Front Immunol; 2023; 14():1289198. PubMed ID: 38022515
[TBL] [Abstract][Full Text] [Related]
5. HORMAD2 methylation-mediated epigenetic regulation of gene expression in thyroid cancer.
Lin Q; Hou S; Guan F; Lin C
J Cell Mol Med; 2018 Oct; 22(10):4640-4652. PubMed ID: 30039914
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation patterns in bladder tumors of African American patients point to distinct alterations in xenobiotic metabolism.
Vantaku V; Amara CS; Piyarathna DWB; Donepudi SR; Ambati CR; Putluri V; Tang W; Rajapakshe K; Estecio MR; Terris MK; Castro PD; Ittmann MM; Williams SB; Lerner SP; Sreekumar A; Bollag R; Coarfa C; Kornberg MD; Lotan Y; Ambs S; Putluri N
Carcinogenesis; 2019 Nov; 40(11):1332-1340. PubMed ID: 31284295
[TBL] [Abstract][Full Text] [Related]
7. Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications.
Lin YZ; Liu WH; Wu YP; Cai H; Zheng QS; Wei Y; Xu N; Xue XY
Int J Immunopathol Pharmacol; 2024; 38():3946320241240706. PubMed ID: 38712735
[No Abstract] [Full Text] [Related]
8. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
Putluri N; Shojaie A; Vasu VT; Vareed SK; Nalluri S; Putluri V; Thangjam GS; Panzitt K; Tallman CT; Butler C; Sana TR; Fischer SM; Sica G; Brat DJ; Shi H; Palapattu GS; Lotan Y; Weizer AZ; Terris MK; Shariat SF; Michailidis G; Sreekumar A
Cancer Res; 2011 Dec; 71(24):7376-86. PubMed ID: 21990318
[TBL] [Abstract][Full Text] [Related]
9.
Pilala KM; Kotronopoulos G; Levis P; Giagkos GC; Stravodimos K; Vassilacopoulou D; Scorilas A; Avgeris M
JCO Precis Oncol; 2024 Apr; 8():e2300414. PubMed ID: 38579191
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation analysis identifies differentially methylated CpG loci associated with severe obesity in childhood.
Huang RC; Garratt ES; Pan H; Wu Y; Davis EA; Barton SJ; Burdge GC; Godfrey KM; Holbrook JD; Lillycrop KA
Epigenetics; 2015; 10(11):995-1005. PubMed ID: 26646899
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide identification of methylated CpG sites in nongenital cutaneous warts.
Al-Eitan LN; Alghamdi MA; Tarkhan AH; Al-Qarqaz FA
BMC Med Genomics; 2020 Jul; 13(1):100. PubMed ID: 32641122
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the Gene Body in
Shen HT; Hung CS; Davis C; Su CM; Liao LM; Shih HM; Lee KD; Ansar M; Lin RK
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785978
[TBL] [Abstract][Full Text] [Related]
14. Plasma metadherin mRNA expression in bladder cancer.
Abd Elhameed ZA; Tag El Din LM; Sherif T; Abdel Aal AM; Moeen AM; Abd El Hakeem EN; Abdelrahman EM
Egypt J Immunol; 2024 Apr; 31(2):28-43. PubMed ID: 38615202
[TBL] [Abstract][Full Text] [Related]
15. Altered Genome-Wide DNA Methylation in the Duodenum of Common Variable Immunodeficiency Patients.
Yang M; Kaarbø M; Myhre V; Reims HM; Karlsen TH; Wang J; Rognes T; Halvorsen B; Fevang B; Lundin KEA; Aukrust P; Bjørås M; Jørgensen SF
J Clin Immunol; 2024 May; 44(6):133. PubMed ID: 38780872
[TBL] [Abstract][Full Text] [Related]
16. Machine learning identifies the role of SMAD6 in the prognosis and drug susceptibility in bladder cancer.
Chen Z; Ou Y; Ye F; Li W; Jiang H; Liu S
J Cancer Res Clin Oncol; 2024 May; 150(5):264. PubMed ID: 38767747
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation based biomarkers in non-invasive cancer screening.
Shivapurkar N; Gazdar AF
Curr Mol Med; 2010 Mar; 10(2):123-32. PubMed ID: 20196733
[TBL] [Abstract][Full Text] [Related]
18. Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers.
Heydari Z; Moeinvaziri F; Mirazimi SMA; Dashti F; Smirnova O; Shpichka A; Mirzaei H; Timashev P; Vosough M
Eur J Pharmacol; 2024 Jun; 973():176563. PubMed ID: 38593929
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer.
Russell PJ; Ow KT; Tam PN; Juarez J; Kingsley EA; Qu CF; Li Y; Cozzi PJ; Martiniello-Wilks R
Cancer Immunol Immunother; 2004 Nov; 53(11):995-1004. PubMed ID: 15449043
[TBL] [Abstract][Full Text] [Related]
20. Identification of a DNA Methylation-Driven Genes-Based Prognostic Model and Drug Targets in Breast Cancer:
Tian S; Fu L; Zhang J; Xu J; Yuan L; Qin J; Zhang W
Front Immunol; 2021; 12():761326. PubMed ID: 34745136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
